Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Inflammatory bowel disease after 1932.

¹Division of Gastroenterology, Box 1069, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029-6574, USA.

The Mount Sinai Journal of Medicine, New York

|June 1, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recurrence of Crohn's disease in end ileostomies.

Inflammatory bowel diseases·2013

Same author

The Appendix and IBD: Appendectomy Does Not Protect Against Ulcerative Colitis.

Inflammatory bowel diseases·2013

Same author

The transformation of medicine by the magic of music in the romances of Shakespeare.

Journal of the Royal Society of Medicine·2001

Same author

Treatment responses in collagenous colitis.

The American journal of gastroenterology·2001

Same author

The placebo response and the "natural history" of inflammatory bowel disease.

Inflammatory bowel diseases·2001

Same author

A family with collagenous colitis, ulcerative colitis, and Crohn's disease.

The American journal of gastroenterology·2001

Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012

Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012

Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012

Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012

Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012

Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012

See all related articles

Inflammatory bowel disease (IBD) research has advanced significantly since the 1930s, focusing on ulcerative colitis (UC) and Crohn's disease (CD). Key developments include understanding disease involvement, complications, and novel therapeutic strategies.

Area of Science:

Gastroenterology
Inflammatory Bowel Disease (IBD) research

Background:

Ulcerative colitis (UC) and Crohn's disease (CD) were clinically defined in the early 1930s.
Major conceptual shifts included recognizing colonic involvement in regional enteritis and the occurrence of cancer and toxic megacolon in both CD and UC.

Observation:

The latter half of the 20th century saw significant gastroenterology contributions to IBD at The Mount Sinai Hospital.
Research focused on extra-intestinal manifestations, CD clinical activity measurement, placebo arm natural history, and complications.
Therapeutic advancements included corticosteroids, 5-ASA, 6-mercaptopurine, immunomodulators, and cyclosporine.

Findings:

Actuarial life tables were applied to analyze postoperative recurrence, re-operation rates, and quality of life.

Related Experiment Videos

Two distinct forms of Crohn's disease were identified: perforating and non-perforating.

The influence of the fecal stream on recurrence risk after surgery, particularly with anastomosis versus ileocolostomy, was investigated.

Implications:

These findings have refined the understanding and management of IBD.
The research provides a foundation for current and future IBD treatment strategies.
Continued investigation into disease mechanisms and therapeutic interventions remains crucial for improving patient outcomes.